Kuros Biosciences AG
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Kuros Biosciences AG generated cash of -$8,844,000, which is less than the previous year. Cash used in financing activities reached the amount of -$171,000 last year. Net change in cash is therefore -$9,857,000.
Cash Flow
| 2014 | -23.75M | 571K | 190K |
|---|---|---|---|
| 2015 | -2.51M | 0 | -12.31M |
| 2016 | -8.89M | 1.81M | 3.46M |
| 2017 | -10.67M | -905K | 15.97M |
| 2018 | -12.83M | -652K | 15.01M |
| 2019 | -10.84M | -118K | 13.12M |
| 2020 | -9.23M | -220K | 17.07M |
| 2021 | -5.45M | -374K | 6.07M |
| 2022 | -7.34M | -400K | 3.22M |
| 2023 | -8.84M | -326K | -171K |
KURN.SW Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 24.06M | 28.62M | 28.38M | 20.80M | 18.33M | 16.67M | 12.36M | 15.94M | 16.93M | 39.84M |
Operating activities | ||||||||||
Net income | -13.72M | -15.99M | -9.55M | -12.09M | -11.82M | -13.81M | -16.59M | -20.27M | 6.22M | -34.02M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.75M | 2.83M | 2.88M | 2.66M | 2.71M | 1.94M | 1.14M | 820K | 4K | 9K |
Stock-based compensation expense | 917K | 1.03M | 389K | 752K | 498K | 0 | 2.03M | 8.47M | 2.53M | 3.74M |
| Deferred income tax benefit | 917K | 1.03M | 389K | 752K | 498K | 0 | 2.03M | 8.47M | 2.53M | 3.74M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -4.57M | -1.64M | -737K | -375K | -476K | 0 | 507K | 0 | -93K | 0 |
Inventories | -2.47M | -1.58M | -340K | -516K | -469K | -337K | -79K | 0 | 0 | 0 |
Accounts payable | 55K | 1.64M | 737K | 375K | 476K | 0 | 0 | 0 | 163K | 0 |
Cash generated by operating activities | -8.84M | -7.34M | -5.45M | -9.23M | -10.84M | -12.83M | -10.67M | -8.89M | -2.51M | -23.75M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -317K | -400K | -374K | -220K | -118K | -662K | -1.57M | -50K | 0 | -20K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 653K | 1.86M | 0 | 0 |
Cash generated by investing activities | -326K | -400K | -374K | -220K | -118K | -652K | -905K | 1.81M | 0 | 571K |
Financing activities | ||||||||||
Common Stock Issued | 501K | 6M | 0 | 18.61M | 14.30M | 16.46M | 16.38M | 3.65M | 16.83M | 190K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -2.37M | -6.4M | -104K | 0 | 0 | 0 | 0 | 160K | 0 |
Cash used in financing activities | -171K | 3.22M | 6.07M | 17.07M | 13.12M | 15.01M | 15.97M | 3.46M | -12.31M | 190K |
Net Change In Cash | -9.85M | -4.55M | 241K | 7.58M | 2.46M | 1.66M | 4.30M | -3.57M | -14.84M | -22.91M |
Cash at end of period | 14.20M | 24.06M | 28.62M | 28.38M | 20.80M | 18.33M | 16.67M | 12.36M | 2.09M | 16.93M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |